Onkologie. 2017:11(1):14-18 | DOI: 10.36290/xon.2017.004
Surgery is a method of choice for the management of localized and locally-advanced renal tumors. In cT1a (up to 4 cm) tumors
nephron-sparing approach (= partial nephrectomy) is current recommended standard, provided it is technically feasible and there
are no contraindications. The amount of nephron-sparing surgeries increases over time also owing to new technologies such as 3D
imaging during surgery, robot-assisted surgery, better hemostatic instruments and greater experience, which all lead to shorter
or no warm ischemia during nephron-sparing surgery. However, there is no long-term functional benefit in elderly patients over
75 years of age. Nevertheless, if preservation of functional parenchyma is needed, thermal ablation methods (radiofrequency ablation
or cryoablation) or active surveillance are possible. In management of locally advanced renal tumors R0 surgery is intended
as adjuvant systemic treatment in not yet the standard. For selected patients with distant metastases surgery, metastasectomy,
is possible. However, only complete metastasectomy of all lesions brings better overall survival.
Published: February 1, 2017 Show citation